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Abstract
Background: While the effects of light as a zeitgeber are well known, the way the
effects are modulated by features of the sleep-wake system still remains to be studied
in detail.
Methods: A mathematical model for disturbance and recovery of the human
circadian system is presented. The model combines a circadian oscillator and a
sleep-wake switch that includes the effects of orexin. By means of simulations, we
characterize the period-locking zone of the model, where a stable 24-hour circadian
rhythm exists, and the occurrence of circadian disruption due to both insufficient light
and imbalance in orexin. We also investigate how daily bright light treatments of short
duration can recover the normal circadian rhythm.
Results: It is found that the system exhibits continuous phase advance/delay at
lower/higher orexin levels. Bright light treatment simulations disclose two optimal time
windows, corresponding to morning and evening light treatments. Among the two,
the morning light treatment is found effective in a wider range of parameter values,
with shorter recovery time.
Conclusions: This approach offers a systematic way to determine the conditions
under which circadian disruption occurs, and to evaluate the effects of light treatment.
In particular, it could potentially offer a way to optimize light treatments for patients
with circadian disruption, e.g., sleep and mood disorders, in clinical settings.
Keywords: Mathematical model of sleep, Circadian rhythm, Entrainment, Orexin
Background
Circadian rhythms indicate a variety of biological oscillations which occur in living
organisms with a period of approximately 24 h [1]. In mammals, the suprachiasmatic
nucleus (SCN) located in the hypothalamus is the central pacemaker for circadian
rhythms [2]. The SCN has a self-sustained, endogenous near-24 h period and gives
cues to various functions of the body, acting as the master clock of the brain. In
particular, the SCN is involved in the timing of the sleep-wake cycle, and applies
increasing sleep pressure as the clock approaches subjective night [3]. The evolution-
ary advantage of the circadian pacemaker is its ability to allow the body to anticipate
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periodic events of the environment. The SCN thus adjusts its phase in response to
the environment and is entrained to the daily cycle. The primary environmental cue
that influences the phase of the SCN is the light-dark cycle. The retinohypothalamic
tract transmits information on light intensity to the SCN [4, 5]. With daily adequate
exposure to light, the entrained SCN ensures that we are active during the day and
at rest during the night [6, 7]. The SCN along with the monoamine nucleus (MA),
ventrolateral preoptic nucleus (VLPO), homeostatic regulators including adenosine,
and orexenergic (ORX) neurons interact to consolidate a stable 24-h sleep-wake cycle
[3, 8–11].
There are sleep disorders where circadian entrainment fails to occur [12]. When
the entrainment fails, the SCN becomes desynchronized with the environment and
the patient experiences drowsiness during the day and sleeplessness during the night.
These sleep disorders often coincide with psychiatric disorders such as depression
[13] or bipolar disorder [14], although the causal relation is not clear. To under-
stand how the entrainment fails, one can conveniently consider a mathematical model
and probe the mechanism via which circadian rhythm destabilization can occur in
the model system. Indeed mathematical models for sleep-wake dynamics have long
accompanied experimental discoveries [15–17]. The Phillips-Robinson (PR) model
[18, 19] bases the sleep-wake system on a flip-flop switch between mutually inhibit-
ing nuclei [10]. The PR model accurately describes core qualitative aspects of sleep,
and can be fit to various experimental observations quantitatively. There have been
studies examining responses of the model to external impulses [20] and noise [21].
It has also been extended in several ways to account for various phenomena related
to sleep, including sleep deprivation [22], caffeine [23], narcolepsy [24], and shift
work [25].
In this study we present an extension of the PR model, incorporating the effects of
both orexin and light. We show that an imbalanced orexin level as well as insufficient
light leads to a loss of the period-locked stable limit cycle in the system and that their
effects are interdependent. Such combined effects have not been probed in previous stud-
ies, which considered only one or the other: Fulcher et al. examined how orexin relates
to narcolepsy [24], but did not explore the effects of orexin on the circadian rhythm.
Postnova et al. developed a circadian oscillator model and applied it to a shift work
setting, but without effects of orexin [25]. Here, to obtain a more complete picture of cir-
cadian entrainment, we use the combined model and study the conditions under which
entrainment occurs. Simulating light treatment, we also quantify the intensity thresh-




The model used in the current study is based on the PRmodel [18]. The core of the model
is the flip-flop switch which arises from two mutually inhibiting neuronal populations,
the VLPO and the MA. The average cell body potentials of these groups are represented
by dynamical variables Vv and Vm, respectively. In addition, we incorporate ORX neurons
with cell potential Vo, following the previous model study of narcolepsy [24]. The time
evolution of the cell potentials is described by the coupled differential equations:












= −Vo + νovQv + νocC + Ao,
where τj is the characteristic time of population j (= v,m.o) and νij (for i, j = v,m, o, c, h)
measures the input from population j to i, with its sign indicating whether the connection
is excitatory or inhibitory [26]. In general νij is proportional to the average number of
synapses from neurons of population j to neurons of population i [27]. Specifically, νmo is
positive, reflecting the wake-promoting effect of orexin. The magnitude of νmo, dubbed
the orexin level, is interpreted to be the amount of orexin neurotransmitters in the brain.
The firing rate Qj of population j takes the form
Qj = Qmax1 + exp [( − Vj)/σ
] , (2)
where Qmax is the maximum firing rate,  the mean firing threshold, and (π/
√
3)σ the
standard deviation of the firing threshold. In Eq. (1), Av, Am, and Ao are constants while
H and C denote the homeostatic sleep drive and the circadian sleep drive, respectively.









with the characteristic time χ , which indicates that H increases during wake (Qm large)
and decreases during sleep (Qm close to zero). The second term on the right-hand side,
where μm and ηh are appropriate constants, describes the saturation behavior of H for
larger values of Qm [24].
The circadian rhythm has been modeled with a modified van der Pol oscillator that
includes photic and non-photic influences [28]. This model has previously been com-





















= qBxc − x
(
δ2 + kB) , (4)
which can be derived via the Liénard transformation of the Van der Pol equation [28].
Here x is the component of the circadian pacemaker that is directly related to the circadian
sleep drive while xc is a complementary variable. Their ratio gives the circadian phase φx
according to tanφx = x/xc. The characteristic frequency	 scales the equation to the 24-h
period and γ is the stiffness constant of the oscillator while constants q and k modulate
the strength of the resetting effect of light via B. Finally, δ measures the intrinsic period
of the oscillator relative to 24 h. Here the intrinsic circadian period of 24.2 h [29] leads to
the value δ = (24 × 3600)/(24.2 × 3600 × 0.997) = 0.994, where the correction factor
0.997 accounts for the nonlinearity of the oscillator.
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The sleep drive C is defined simply to be C = x while the photic and non-photic
influences B and Ns on the circadian oscillator are expressed as







[1 − tanh(rx)] (5)
where G, ε, and r are constants and n is the fraction of photoreceptor cells that are acti-
vated . The first one of Eq. 5 has been chosen to characterize the varying sensitivity of
the circadian oscillator to light throughout a day. Here ρ is the rate constant while s is the
state variable taking the value unity (s = 1) for the waking state and zero (s = 0) for the
sleeping state. It thus reads s = θ(Vm −Vthm ), where θ is the Heavyside step function with
the threshold mean MA potential Vthm = −2mV above which the system is defined to be
in the waking state.
The rate of conversion from the ready state to the activated one of photoreceptors
depends on the light intensity I via α:
dn
dt







I + I1 , (7)
where β describes the rate of conversion from the activated state to the ready state. The
form of α and constants α0, I0, I1, and p have been taken from [28] to fit the intensity
response curve in high- and low-intensity ranges. Specifically, α increases with the light
intensity in proportion to I3/2 at low intensities and to I1/2 at intensities much higher than
I1. The light intensity I(t) affecting the photoreceptor cells is given by the environmental
light Ĩ(t) along with the gating effect:
I(t) = s̃I(t). (8)
In this manner the photic driving force is gated by the sleep-wake state. Henceforth the
tilde sign on Ĩ will be omitted for simplicity.
Note that Eqs. (4) to (8) are not present in Fulcher et al. [24], which adopted a fixed
sinusoidal function tomodel the sleep driveC. This was adequate in that study, given their
purpose of modeling narcolepsy, a state of unstable sleep-wake patterns. The addition of
a circadian oscillator here allows us to probe the effects of orexin on a different kind of
instability, circadian disruption. The circadian oscillator model was developed to respond
realistically to broad ranges of the light intensity and duration. In particular, it describes
accurately the human phase-response curve to light[28]. We have found that the phase-
response curve remains nearly unchanged in the integrated model, with the sleep-wake
circuitry added.
The resulting sleep-wake model is illustrated schematically in Fig. 1, which exhibits the
components of the model and interconnections between them. As given in the caption,
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Fig. 1 Schematic diagram of the sleep-wake model exhibiting components and their interconnections.
Pointed-ends represent excitatory connections, while flat-ends represent inhibitory connections
pointed-ends represent excitatory connections between components whereas flat-ends
represent inhibitory connections.
Nominal parameters and light input
The nominal parameters used are shown in Table 1. Parameters involving the sleep-wake
switch and homeostatic sleep drive have been taken from [24] and those involving the cir-
cadian oscillator taken from [25]. We further adjust a few parameters to produce realistic
results, e.g., χ = 40 h to produce a stable 8-h daily sleep bout with the 24-h period.
Table 1 Nominal parameter values of the model
Sleep-Wake Switch Circadian Pacemaker
Parameters Values Units Parameters Values Units
Qmax 100.00 s−1 	 7.2722 × 10−5 s−1
 10.000 mV γ 0.13000 −
σ 3.000 mV q 0.60000 −
νvm − 2.1000 mVs k 0.51000 −
νmv − 1.8000 mVs δ 0.9944 −
νvc − 0.3000 mV β 0.0070000 s−1
νvh 1.0000 mV α0 0.100000 s−1
νoc 1.0000 mV p 0.5 −
νmo 0.30000 mVs I0 9500 lux
νov − 1.0000 mVs I1 100 lux
τv , τm 10 s G 2220.0 s
τo 120 s ρ 0.032000 −
χ 40.000 h ε 0.40000 −
μm 17.000 − r 10.000 −
ηh 2.3000 s−2 Id 600 lux
Av − 8.5000 mV In 150 lux
Am 0.52000 mV Td 11.000 h
Ao 1.0000 mV
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The environmental light is modeled as a simple square waveform:
I(t) =
{
Id for 12 h − Td/2 ≤ t∗ < 12 h + Td/2
In otherwise,
(9)
where t∗ is defined to be tmodulo 24 h and corresponds to the day time. Accordingly, I(t)
is given by a 24 h-periodic square function with Td hours of daylight of intensity Id and
24−Td hours of dim light of intensity In. The dynamical equations are then periodic with
period 24 h, corresponding to the 24-h day-night cycle. For our nominal parameter set,
we use Id = 600 lux, In = 150 lux, and Td = 11 h (see Table 1).
Figure 2 exhibits the resulting dynamics of the model. Specifically, the time evolutions
of seven dynamical variables: the fraction n of activated photoreceptor cells, circadian
oscillator variables x and xc, sleep drive H, and cell potentials Vv, Vm, and Vo of VLPO,
MA, and ORX neurons, respectively, are plotted, together with the input light intensity I,
during 48 h.
For a later purpose, we also remark that the circadian phase is related to the core body
temperature (CBT) minimum via [28]
tCBT,i = tφ,i + td, (10)
Fig. 2 Plot of model dynamics during 48 h for the nominal parameters in Table 1. The light input I (in units of
lux), having a 24-h period, results in a stable 24-h sleep-wake cycle, as manifested by the behaviors of seven
dynamical variables: n, x, xc , H as well as cell potentials Vv , Vm , and Vo (in units of mV)
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where tCBT,i is the time of the CBT minimum on the ith day and tφ,i is the time at
which the circadian phase takes the value φx = −170.7◦ on the same day i. The time lag
between the two is given by td = 0.97 h. The average phase shift between CBT minima of









where N is the total number of days of concern.
Results
Period locking zone
We now study the dynamics of the model by means of simulations, employing the 4th-
order Runge-Kutta method. Numerical integration of the equations describing the model
with the nominal parameters in Table 1 results in a stable 24-h limit cycle, which is inter-
preted as successful light entrainment: The circadian oscillator is coupled well to the light
Zeitgeber, via the term B in Eq. (4), and the circadian oscillator in turn fixes the sleep-
wake cycle [Eq. (1)], so that sleep occurs during the dark phase and wake occurs during
the light phase.
Performing simulations in the absence of light (Id = In = 0), we find that the system
exhibits a limit cycle with a period of 24 h and 22 min. Hence if the strength of light is
weakened, the intrinsic period of the system will overcome the effects of light and there
will be a constant phase delay. The critical daylight intensity at which the stable state
disappears corresponds to the period-locking bifurcation point.
On the other hand, when the orexin level νmo is varied, this intrinsic period is altered
by the change in the phase and length of the non-photic influence Ns: A higher values of
νmo leads to a longer period. This is an alternate way in which stability can disappear.
We carry out simulations of the model using a range of values of νmo and Id. To be spe-
cific, we sweep the νmo-Id parameter space, and take values of νmo ranging from 0.2mV s
to 0.35mV s with increments of 0.0002mV s and of Id from 150 to 16,000 lux with incre-
ments of 10 lux. For each pair of parameters, simulations have been performed for the
duration of 60 weeks, of which the data for the first 20 weeks are discarded for equilibra-
tion. Accordingly, the average phase shift  in Eq. (11) is obtained via averaging over the
last 40 weeks (i.e.,N = 280 days). The resulting heatmap plot of the phase shift  is given
in Fig. 3a. The red region indicates the period-locked zone, where no phase shift arises
( = 0).
The boundaries of this zone are depicted in Fig. 3b for two different values of daytime
duration Td. When the total exposure to bright light is low as in winter (Td = 9 h), the sta-
bility region is observed to be reduced appreciably. On the other hand, extended duration
of daytime (Td = 11 h) tends to widen the stable region.
Figure 3 manifests that there are three routes to the loss of the 24-h period: (1) by
decreasing the daytime duration Td , which shrinks the area of the period-locked zone; (2)
by lowering the daylight intensity Id, which amounts to moving left on the νmo-Id param-
eter plane; and (3) by changing νmo, which corresponds to moving up or down on the
parameter plane.
The sleep-wake system maintains a stable 24-h cycle by means of its phase-resetting
response to light. When daylight is insufficient, the photic driving force is not enough
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Fig. 3 a Average shift  of the CBT minimum, obtained via simulations with Td = 11 h, in the νmo-Id
parameter space. b Period-locking zone boundaries for two different values of Td . Points are marked for
normal (circle), seasonal disorder (square), and non-seasonal disorder (triangle). The arrows indicate shifts
from the normal state to the disordered states (see the text). Note that in simulations the leftward arrow (shift
to seasonal disorder) is accompanied by a change in Td from 11 h to 9 h. The area enclosed in the the dotted
box is enlarged in the inset
for entrainment to occur. This is the case in routes (1) and (2) above. However, route
(3) shows that an imbalance in orexinergic neurons can cause circadian disruption even
when daylight is typically sufficient. The mechanism by which this occurs is due to the
wake-promoting nature of ORX. When νmo is increased, sleep and wake onset times are
delayed with respect to the phase of the circadian oscillator. Due to the gating effects
present in the photic drive B, this causes more light to enter the system at subjective night
and less to enter in the subjective morning. The human phase response curve is such
that morning light causes phase advance and evening light causes delay. In consequence
the increase in ORX causes phase delay. Similar effects are observed when a constant
excitatory stimulation term is added to ORX; this may be achieved simply by increasing
the constant Ao.
Diseased states and light treatment
The above results show that both lack of daylight and high orexin levels can cause destabi-
lization in the timing of the onset of sleep. The former is thought to be the case in seasonal
affective disorder while the latter is regarded as a possible mechanism for non-seasonal
affective disorder. Here we examine the effects of light treatment on such diseased states.
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We first simulate bright light treatment in the case of insufficient light, which con-
sists in artificial exposure to strong white light for a short time (e.g., 1.5 h). Simulations
begin in the limit cycle of the model with nominal parameters; then the daylight
length Td and intensity Id are reduced linearly, from 11 to 9 h and from 600 to 520
lux, respectively. This is intended to simulate a rapid change into winter light condi-
tions, inducing circadian phase shifts to become increasingly misaligned with the light
input.
We then consider the treatment by applying light of intensity Itr in addition to the
underlying (environmental) light in Eq. (9). During four days into full winter, light treat-
ment is applied daily by taking Itr = 10, 000 lux for an hour and half each day. Light
treatment protocols vary across studies; here the intensity and duration of light has been
adopted from the study of light treatment as an antidepressant [30]. Treatment begins
at time t0 of each day, which we set to 7 am unless stated otherwise. If the time tCBT of
the CBT minimum drifts towards a stable time within an hour from its initial value, we
consider the system to be recovered.
In winter simulations, the wake onset time is retarded under the winter conditions and
becomes desynchronized with light in the absence of light treatment. When light treat-
ment is applied, the wake onset is advanced from the delayed phase and settles into the
value near its initial phase of 10 pm, indicating recovery.
Next, we simulate a diseased state under normal light circumstances, where the insta-
bility is caused by an abnormal value of νmo. We see in Fig. 3 that there are two ways
in which this can happen: one by a large value of νmo, where sleep timing is constantly
delayed, and the other by a low value of νmo, where sleep is advanced. Here we illustrate
the former case only.
Figure 4 presents the result of the non-seasonal case. Starting on day 10, we raise νmo
from 0.3 to 0.31 mV s, which lies above the stable zone in Fig. 3a, while keeping Id and Td
in their nominal values. As in the seasonal case, stability is restored when light treatment
is applied and the system returns to a normal sleep-wake cycle. Thus the model shows
that light treatment has stabilizing effects even when the instability does not arise from
the lack of environmental light.
Optimal light treatment times
We now explore how the efficacy of bright light treatment depends on the timing of treat-
ment. Figure 5a demonstrates the sensitive dependence of the recovery time tr, i.e., the
time duration of treatment required for a return to the initial phase, on the beginning time
t0 of light treatment in the case of non-seasonal depression, for two values of νmo. Note
that in the case of νmo = 0.31mV s, recovery occurs in the two limits of the treatment
timing: one in the morning and the other in the afternoon. When νmo = 0.315mV s, the
recovery time for morning recovery is increased while afternoon recovery ceases to work.
It is suggested in Fig. 5a that in the case of phase-delay instability, both morning and
evening bright light treatments are effective although morning treatment will be effica-
cious in a larger range of parameters. To make clear the difference in the efficacy between
morning and afternoon treatments, we select two representative values of t0 correspond-
ing to morning (t0 = 7:00) and afternoon (t0 = 15:00) treatments. For each treatment
time, we calculate the light treatment intensity Itr at which recovery occurs for varying
orexin levels.
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Fig. 4 Daily sleep times (black lines) and CBT minima (colored dots) during simulations of light treatment on
non-seasonal affective disorder. The orexin level is increased on day 7 (indicated by an arrow), causing
instability. Starting on day 14 (indicated by another arrow), morning light treatment of 10,000 lux for 1.5 h
daily is administered and maintained during the times labeled yellow, which causes a gradual return to the
normal phase
This leads to a phase diagram on the Itr-νmo plane, which is shown in Fig. 5b. It is
observed that for all values of νmo, the required treatment intensity is much larger for
afternoon treatment. It is also observed that the required treatment intensity Itr grows
rapidly with νmo. Specifically, at νmo = 0.32mV s, the intensity Itr becomes unrealistically
large, indicating that only morning treatment is feasible. As νmo is increased further, e.g.,
to νmo = 0.34mV s, this light treatment scheme becomes unfeasible at any intensity.
Effects of noise
Noise is an important aspect of a realistic biological system. Here we consider the effects








= −Vm + νmvQv + νmoQo + Am + Dξm(t), (12)
where the added terms ξj (j = v,m) are Gaussian white noise characterized by 〈ξj(t)〉 = 0
and 〈ξj(t)ξj(t′)〉 = δ(t − t′) with noise strength D. Following existing studies [24, 31],
we choose not to add noise to the ORX equation; we expect that doing so would bring
additional noise in the MA neurons and not affect significantly the results.
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Fig. 5 a Recovery time tr (in units of day), i.e., days of treatment required for recovery from the circadian
instability caused by orexinergic imbalance, versus treatment timing t0, for two values of νmo . Interpolation
has been used to produce a smooth curve. b Phase diagram on the Itr-νmo plane, for morning treatment
(t0 = 7 am) and afternoon treatment (t0 = 3 pm). Above the curves, recovery occurs
Starting from the periodic solution, we perform simulations for 90 days, so as for the
circadian system to settle possibly into its new equilibrium. We then simulate additional
40 days and observe whether circadian phase shifts occur. This process is repeated 50
times with new random seeds. Initially, the noise level is taken to be D = 0.01mV, and
the entire process is repeated with D increased in increments of 0.01mV.
Figure 6a shows the distribution of the CBT minimum time tCBT,i over the last 40 days
of simulations for the range of D considered. It is observed that the circadian phase shifts
to earlier timings as the noise level is increased. Moreover, noise tends to provoke the
CBT timing (specified by tCBT,i) to spread: For instance, the standard deviation of tCBT,i
takes the value of about 7 min at D = 0.1mV. When the noise level is low (D < 0.21mV),
the system settles into a new equilibrium within 90 days and the distribution of tCBT,i
does not change significantly over the next 40 days. In other words, periodicity, albeit
fluctuating, is preserved. AtD = 0.21mV, however, there appears a slight advance, which,
for D > 0.21mV, increases substantially; this indicates that circadian disruption occurs at
D = 0.21 ± 0.01mV. When D is increased further to the order of 1mV, noise dominates
the sleep-wake switch and drives the system to switch erratically between sleep and wake.
Due to the phase advance effect described above, we expect the stability landscape of
Fig. 3a to change with the introduction of noise. Setting D = 0.1mV, we perform simula-
tions with νmo varied about its nominal value in increments of 0.001 mV s, and find that
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Fig. 6 a Core body temperature minimum time tCBT,i versus noise level D, obtained from simulations. The
averages and standard deviations are plotted for the 90th, 110th, and 130th days (blue, green, orange) for
D = 0.01mV to 0.25mV. b Light treatment simulations for νmo = 0.33mV s, treatment time t0 = 7:00, and
Itr = 10, 000 lux, in the presence of noise D = 0.1mV. As in the case without noise, recovery to the normal
phase is observed
circadian entrainment occurs in the range 0.244 mV s ≤ νmo ≤ 0.321 mV s, below/above
which continuous phase advance/delay is observed. This range is to be compared with
that in the absence of noise (D = 0mV), namely, 0.229 mV s ≤ νmo ≤ 0.305 mV s. Such a
shift of the stability region toward higher orexin levels indicates that the addition of noise
offsets some of the phase-delaying effects of orexin. Finally, we simulate morning bright
light treatment withD = 0.1mV, νmo = 0.33mV s, t0 = 7:00, and Itr = 10, 000 lux, to find
that the system undergoes recovery to the normal phase [see Fig. 6b].
Discussion
The results of the integrated sleep-wake model provides a mathematical basis for many
results established as to circadian entrainment. For example, many blind individuals expe-
rience a cyclic sleep disorder: They experience normal sleep-wake behavior for days to
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weeks at one time, followed by difficulty in sleeping at night and staying awake during the
day for a period of time. Observation of such patients discloses that they experience con-
tinuous phase delay [32, 33]. Such patients are not entrained to light because they lack
stimulation via the retinohypothalamic tract. Assuming nominal parameters otherwise,
we should expect behavior corresponding to the upper left-most region in Fig. 3a, which
does indicate continuous phase delay.
In sighted individuals, failure of entrainment results in non-24-h sleep-wake syndrome,
similar to the above case. On the other hand, there are cases where the circadian phase is
period-locked but at an abnormal time. This is the case in delayed sleep phase syndrome
or advanced sleep phase syndrome, where the patient has a 24-h circadian rhythm but
with a phase significantly late or early relative to the socially acceptable time. Namely,
the system locates on the right of the curves in Fig. 3, but has a late or early phase due
to an abnormal orexin level or inadequate exposure to light. Previous studies reported
that delayed sleep phase syndrome arises in both circadian and sleep homeostatic systems
[34]; our model offers a way to examine the interplay of those contributions, and although
this issue is not explicitly explored in this study, it should be explored in the future.
Circadian rhythm disruption is known to be important in seasonal affective disorder,
where change in the intensity and duration of light exposure is involved [13, 35]. In our
model, we have seen that this corresponds to moving to the left on the parameter plane of
Fig. 3b and shrinking the period-locking curve. The restoration of entrainment via bright
light treatment as seen in our model is a possible mechanism behind the reported effi-
cacy of bright light treatment as an antidepressant in seasonal affective disorder [35, 36].
Note here that lack of light exposure is not the only cause of circadian instability and that
there is there is also evidence for the effectiveness of the bright light therapy in treatment
of nonseasonal mood disorders [37, 38]. Relatedly, ORX neurons are implicated both in
sleep disorders and in mood disorders [39]; our model study has shown that circadian
disruption is a channel through which these effects may occur.
Our results thus demonstrate two different channels through which circadian disrup-
tion can occur: lack of light and orexin imbalance. Moreover, it shows that bright light
treatment can be effective in restoring a normal circadian rhythm in both cases. In the
case of orexin imbalance, Fig. 5 shows that the there are two time windows during which
bright light treatment is effective, with morning treatment being effective for a wider
range of circumstances. This result is consistent with the fact that morning bright light
treatment is generally more effective than evening treatment in clinical studies. For exam-
ple, Avery et al. [40] studied changes in the Hamilton Rating Scale for Depression (HRSD)
scores after bright light treatment in winter depression, and found that morning treat-
ment resulted in significantly higher remission rates compared with evening treatment.
With refinement, our approach can be used to predict the efficacy of bright light treat-
ment in specific circumstances and to guide practical applications. In that regard, it would
be desirable to have more rigorous fitting to experimental results, based on, e.g., system-
atic investigation of the noise effects on entrainment conditions and the efficacy of bright
light treatment.
Conclusion
Amodel study was presented investigating circadian entrainment, disruption, and recov-
ery. This study is the first attempt at a combined framework thatmodels the effects of light
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and orexin on the entrainments. The approach provides a way to determine the conditions
under which circadian disruption occurs, to evaluate the effects of light treatment, and to
identify optimal treatment times. Light treatment methods could be costly, and it would
be desirable to determine specifically the optimal time of day and the required intensity
of light in applying the therapy. The results are consistent with light treatment data, and
make a first step towards useful methodology for light treatment determination. To deter-
mine optimal light treatment for actual patients using this model, one needs to calibrate
various parameters more precisely and to take individual variations into consideration;
this is left for future study.
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